InvestorsHub Logo

Dr Bala

02/23/20 8:08 PM

#266902 RE: maverick_1 #266893

Great post, as always, Mav.

sukus

02/23/20 8:51 PM

#266910 RE: maverick_1 #266893

Thanks for the post Mav. Last week was such a roller coaster. It hit .14 before our eyes. As a senior investment pro with decades of experience in the industry, what is your take on the future that might come true? Do you feel TLD is coming? What is “interesting” that you might feel going to happen in the ASM?

hyperopia

02/23/20 11:21 PM

#266930 RE: maverick_1 #266893

Thanks maverick. I missed many of those.

Doc logic

02/25/20 12:50 PM

#267446 RE: maverick_1 #266893

maverick_1,

I use a cheat sheet of sorts. I try to stay ahead with the science which tells me where this will eventually get to if it can survive, which due diligence on Linda confirmed would happen, but watch the charts for the cycles for when to buy. NWBO earned my support by choice through the ups and downs with cost averaging. Low cost basis now. Enrolling 331 vs 348 sealed the deal because I was certain they left out German SOC patients. That is something they could have cleared up but never did by choice obviously. They have 4 year plus data now for comparative purposes and they already showed us the improving blinded outcomes. Mr. Pearlmutter is a "Johnny come lately" for me. Triozi et al set up the scientific premise/basis for expected long term success. Knowing Linda's character and tenacity was the reason to expect it to get there. Best wishes.

flipper44

02/25/20 1:21 PM

#267455 RE: maverick_1 #266893

Maverick, I thought you said the stars were suppose to align for topline on December 6, 2019, then in mid December 2019? Are your stars in the Southern Hemisphere?